-
Benevis Enters Voluntary Chapter 11 Reorganization
Post on 8/3/20
-
2020’s Best & Worst States for Health Care – WalletHub Study
Post on 8/3/20
-
Inhibikase Therapeutics Starts $18 Million IPO Effort
Post on 7/30/20
-
A Mask Mandate is Good for Our Health – and Our Economy
Post on 7/22/20
-
Metaclipse Therapeutics Awarded Funding from NIAID for COVID-19 Vaccine Development
Post on 7/21/20
-
Proper Nutrition, Starting with Daily Celery Juice, is Key to Building Healthy Immune System
Post on 7/20/20
-
Clinigence Holdings Provides Strategic Update
Post on 7/19/20
-
Ambu Receives FDA Clearance for its Sterile, Single-use Duodenoscope
Post on 7/17/20
-
How to Spot a Scam Supplier of PPE
Post on 7/16/20
-
Nephron Pharmaceuticals Corporation Announces Historic Expansion in Lexington County
Post on 7/13/20
-
GALT Announces Commencement of Patient Enrollment of Phase 2b/3 Trial in NASH
Post on 6/30/20
-
Medical Device Maker Ambu and Medical Advisory Fuel Medical Group Announce Partnership
Post on 6/30/20
-
States that Have the Fewest Coronavirus Restrictions – Updated WalletHub Study
Post on 6/23/20
-
States with the Biggest Health Improvements During COVID-19 – WalletHub Study
Post on 6/10/20
-
Sharecare Acquires MindSciences
Post on 6/3/20
-
Cities with the Biggest Increases in Unemployment Rates Due to COVID-19 – WalletHub Study
Post on 6/3/20
-
States with the Best Health Infrastructure for Coronavirus – WalletHub Study
Post on 5/26/20
-
Drug Use by State: 2020’s Problem Areas – WalletHub Study
Post on 5/13/20
-
Medical Device Maker Ambu Launches New Single-Use Cystoscope for Improved Workflow and Enhanced Productivity Benefits
Post on 5/12/20
-
States with the Most Vulnerable Populations to Coronavirus – WalletHub Study
Post on 5/12/20
-
AYA Medical Spa Joins Colony Square’s Service-Focused Retail Mix
Post on 5/11/20
-
CDC Foundation Sources PPE From Stoltz One to Protect Vulnerable U.S. Health Care Workers on the Front Lines
Post on 5/7/20
-
Tracking Risk of COVID-19 Stimulus Packages
Post on 5/7/20
-
Polar Pak to Produce 2M Face Shields for Health Canada to Help Fight the COVID-19 Pandemic
Post on 5/6/20
-
Galectin Therapeutics Submits Seamless Adaptively-Designed Phase 2b/3 NASH-RX Protocol in NASH Cirrhosis
Post on 5/1/20
Atlanta
